RecruitingPhase 3NCT07228104

Use of Steroid Injections to Prevent the Recurrence of Tracheal Stenosis in Idiopathic Subglottic Stenosis

Adjuvant STeRoid Outcomes in Idiopathic Subglottic Stenosis

Sponsor

Johns Hopkins University

Enrollment

226 participants

Start Date

May 20, 2026

Study Type

INTERVENTIONAL

Conditions

Idiopathic Subglottic Stenosis

Summary

This study will examine the ability of steroid injections into the site of stenosis following surgical dilation to delay the need for repeated surgical dilations.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Triamcinolone 0.1% for people with idiopathic subglottic stenosis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTriamcinolone 0.1%

Intralesional Triamcinolone injection 3x at one, two, and three months following surgical dilation

DRUGPlacebo

Intralesional Placebo injection 3x at one, two, and three months following surgical dilation

Locations(1)

Johns Hopkins Hospital

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07228104